Skip to content
Toggle main navigation
Home
More
Open dropdown to see remaining menu items
Log in
USAP Reaches Agreement in Principle with Federal Trade Commission
Published on April 23, 2026
USAP Reaches Agreement in Principle with Federal Trade Commission
Jodi_Lewis
Thu, 04/23/2026 - 09:26
Read more
about USAP Reaches Agreement in Principle with Federal Trade Commission
Continue reading on website
Other news
Insights from Frost & Sullivan’s VP of Healthcare & Life Sciences on Abzena Emerging as an ADC CDMO Leader in Frost Radar Report
April 22, 2026
The global antibody‑drug conjugate (ADC) landscape is undergoing rapid expansion, fuelled by a surge in clinical pipeline progression, next‑generation payload innovation, and the intensifying need for integrated development and manufacturing partners. Within this competitive environment, Abzena has secured a prominent position in Frost & Sullivan’s Frost Radar™: ADC Contract Development and Manufa
Part 2 of 3: The Importance of Developability Assessments – From Design to Selection – How Developability Guides Effective Lead Optimization
April 23, 2026
Authors: Dr. Rob Holgate, Vice President of Research & Innovation, and Dr. Gary Watts, Director of Formulation Development at Abzena Key takeaways from this article:Developability assessment should be integrated early – from design through lead selection – to identify liabilities beyond potency, including stability, safety, and manufacturability.Evaluating developability alongside biological activ
